Citation Impact
Citing Papers
Comprehensive computational design of ordered peptide macrocycles
2017 StandoutScienceNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Multidrug resistance: molecular mechanisms and clinical relevance
1997
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies
2005
Targeting cancer metabolism: a therapeutic window opens
2011
Resident vascular progenitor cells: An emerging role for non-terminally differentiated vessel-resident cells in vascular biology
2008
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
2009
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR
2002 Standout
Interferon-Induced Sarcoidosis
2006
Early Identification of Refractory Epilepsy
2000 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, andmdr gene expression in colorectal cancer
1993
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
1995 Standout
Senescence, apoptosis and therapy — cutting the lifelines of cancer
2003
Evaluation of RNA Isolation Methods and Reference Genes for RT-PCR Analyses of Rare Target RNA
2000
A new mathematical model for relative quantification in real-time RT-PCR
2001 Standout
Gestational trophoblastic disease
2010 Standout
Acute Lymphoblastic Leukemia
1998
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
Generation of Induced Pluripotent Stem Cells from Human Cord Blood
2009
Scleroderma
2009 Standout
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
2001 Standout
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
2011 StandoutNature
A DNA damage checkpoint response in telomere-initiated senescence
2003 StandoutNature
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
2005
MAP kinase signalling pathways in cancer
2007 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
C-Raf Inhibits MAPK Activation and Transformation by B-RafV600E
2009
Regulation of PDGF and its receptors in fibrotic diseases
2004
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Aspergillosis
2002
Translational implications of somatic genomics in acute myeloid leukaemia
2014
The biology of the P-glycoproteins
1995
Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice
2002
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
2002
Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy
1993
Stem cells in tumor angiogenesis
2010
Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells
2008
Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase
2006
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
Infectious agents and lymphoma development: molecular and clinical aspects
2009
Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics
2001
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Non‐comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation
2006
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization — A review of current strategies
2009
GCN2 Protein Kinase Is Required to Activate Amino Acid Deprivation Responses in Mice Treated with the Anti-cancer Agent l-Asparaginase
2009
Sarcoidosis
2007 Standout
CARMA1, BCL-10 and MALT1 in lymphocyte development and activation
2004
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
2000
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
The gastric marginal zone B-cell lymphoma of MALT type
2000
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells
1998
Acute Myeloid Leukemia
2015 Standout
AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
1995
eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation
2016 StandoutNatureNobel
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
2003
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
2000
Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein.
1993
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
1997
Combination Antifungal Therapy
2004
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals
2006
Transduction of Murine Bone Marrow Cells With an MDR1 Vector Enables Ex Vivo Stem Cell Expansion, but These Expanded Grafts Cause a Myeloproliferative Syndrome in Transplanted Mice
1998
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial
2003
Compact Cysteine-Coated CdSe(ZnCdS) Quantum Dots for in Vivo Applications
2007 StandoutNobel
AspergillusInfections in Transplant Recipients
2005
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia
1996
The glutaminase activity of l-asparaginase is not required for anticancer activity against ASNS-negative cells
2014
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
2003
Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
2003
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
2008 StandoutNobel
Transduction of Murine Bone Marrow Cells With an MDR1 Vector Enables Ex Vivo Stem Cell Expansion, but These Expanded Grafts Cause a Myeloproliferative Syndrome in Transplanted Mice
1998
"Infectious" Transplantation Tolerance
1993 StandoutScience
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells
2012 StandoutNobel
Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype [see comments]
1992
Wound Healing: A Cellular Perspective
2018 Standout
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
2009
Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation
2012
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
Continuous liquid interface production of 3D objects
2015 StandoutScience
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients1
2002
Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients
2003
The gastric marginal zone B-cell lymphoma of MALT type
2000
Immunosurveillance of Alglucerase Enzyme Therapy for Gaucher Patients: Induction of Humoral Tolerance in Seroconverted Patients After Repeat Administration
1999
Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis
2002
Combinatorial Peptide Libraries: Mining for Cell-Binding Peptides
2013
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
The structure of the human CD2 gene and its expression in transgenic mice.
1988
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
Dual inhibition of c‐abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
2008
Engineering Complex Tissues
2012
Works of Werner Linkesch being referenced
Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma
2002
Rapid Large-Scale Expansion of Functional Mesenchymal Stem Cells from Unmanipulated Bone Marrow Without Animal Serum
2008
MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia
1991
Asparaginase‐induced derangements of glutamine metabolism: the pathogenetic basis for some drug‐related side‐effects
1988
Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas
1997
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
1996
Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate
2001
THERAPY WITH RECOMBINANT INTERFERON ALPHA‐2c DURING UNEXPECTED PREGNANCY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA
1992
Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia
2011
PCR‐monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR‐ABL‐positive acute lymphoblastic leukaemia
1995
Chlamydia psittaci in MALT lymphomas of ocular adnexals: The Austrian experience
2007
Blood Monocytes Mimic Endothelial Progenitor Cells
2005
Immune Cells Mimic the Morphology of Endothelial Progenitor Colonies In Vitro
2007
Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha
1992
Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B
2000
The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling
2007
Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis
2002
Two Transforming C-RAF Germ-Line Mutations Identified in Patients with Therapy-Related Acute Myeloid Leukemia
2006
AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
1994
Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia
1985
Granulocyte Colony-Stimulating Factor as an Adjunct to Induction Chemotherapy for Adult Acute Lymphoblastic Leukemia — A Randomized Phase-III Study
1997